AptaPharma recalls

FDA enforcement reports naming AptaPharma Inc. as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: May 4, 2022

Severity

May 4, 2022Wal-Tussin DM (dextromethorphan HBr/Guaifenesin), 12 FL OZ (354 mL) bottles, Distribute…Drug · AptaPharma Inc.Incorrect/Undeclared Excipient: Product contains alcoholClass III